Navigation Links
Allscripts to Announce Second Quarter Fiscal 2010 Results
Date:12/16/2009

CHICAGO, Dec. 16 /PRNewswire-FirstCall/ -- Allscripts (Nasdaq: MDRX) announced today that it will report its financial results for the three and six months ended November 30, 2009 before the stock market opens on Monday, January 11, 2010. Allscripts management will host a conference call and webcast to discuss the company's earnings and other information at 8:30 AM Eastern Standard Time that same morning.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

Allscripts fiscal second quarter earnings will be released to coincide with the announcement of results for the six months ended November 30, 2009 by Misys PLC, expected to be scheduled for the week of January 11, 2010.

More details on the call

The Allscripts earnings announcement will be distributed via PR Newswire at 7:00 AM Eastern Standard Time on January 11, 2010. The press release also will be available on the company's website at www.allscripts.com.

To listen to the conference call, participants may log onto www.allscripts.com. Participants are encouraged to log onto the website approximately 15 minutes prior to the start of the conference call to download and install any necessary software. Participants also may access the conference call by dialing (866) 516-9093 (in the U.S.) or (973) 532-4923 (international) and requesting the Allscripts investor call. A replay of the call will be available three hours after the conclusion of the call, for a period of two weeks, at www.allscripts.com or by calling (800) 642-1687 or (706) 645-9291 - ID # 46110827.

Minimum system requirements to listen to the Web version of the call are: an Internet connection, speakers or earphones, and Microsoft Windows Media Player software, downloadable for free from http://windowsmedia.com/download/download.asp.

Upcoming Investor Presentations

Allscripts will present at the following investor events:

  • January 12, 2010 at the J. P. Morgan Healthcare Conference, to be held in the Westin St. Francis, San Francisco
  • January 26, 2010 at the Jefferies Global Healthcare Services Conference, to be held in the Mandarin Oriental Hotel, New York City
  • February 8, 2010 at the UBS Global Healthcare Services Conference, to be held in the Grand Park Hyatt, New York City
  • February 25, 2010 at the Oppenheimer & Co. Healthcare Information Technology 1:1 Conference, to be held at Oppenheimer & Co., New York City
  • March 3, 2010 at the Raymond James and William Blair HIMSS Booth Tour, to be held in the Georgia World Congress Center, Atlanta
  • March 8, 2010 at the Raymond James & Associates Annual Institutional Investors Conference, to held in the JW Marriott Orlando, Grande Lakes, Orlando

The presentations may be accessed live or as archived files at www.allscripts.com under the "Company" menu (click "Investor Relations").

About Allscripts

Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and nearly 8,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.

For more Allscripts news, follow us on Twitter at: http://twitter.com/AllscriptsMisys

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Allscripts-Misys Healthcare Solutions, Inc.


'/>"/>
SOURCE Allscripts-Misys Healthcare Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
2. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
3. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
4. Allscripts Featured in Microsoft HealthVault Worldwide Launch
5. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
6. Allscripts to Announce Third Quarter 2007 Results on November 8th
7. Allscripts Reports Third Quarter 2007 Results
8. Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report
9. Allscripts Adds TeamPraxis Quality Reporting Software for Electronic Health Records
10. ProHealth Physicians Selects Allscripts Electronic Health Record and Practice Management for 240 Providers
11. Mankato Clinic Selects Allscripts Electronic Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... Egg freezing and embryo freezing are both ... slight statistical advantage for live births, frozen eggs offer many advantages, depending on ... medical treatment or who are concerned about the decline of their fertility as ...
(Date:9/21/2017)... ... 2017 , ... SABRE is raising awareness about personal safety with a Chicago ... November. , The Chicago, Illinois, based self-defense brand has been waiting for an opportunity ... of taking their personal safety into their own hands. , The ads focus on ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Bill Howe ... to its customers, and give back to the community. For over 37 years, they ... most successful companies serving plumbing in San Diego. They were chosen as ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, ... Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East ... pieces, such as Zen Kodo mat. Wanderlust , one of the largest US ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
(Date:8/29/2017)... 29, 2017 ivWatch, LLC, the leading provider of continuous ... it has been awarded an Innovative Technology contract from Vizient, Inc., ... ... aid in the early detection of peripheral IV infiltration and extravasation ... The Innovative Technology contract was awarded ...
Breaking Medicine Technology: